Management of Expiration Dates and Health Harm Risks for Products We Handle
First written in FY2020. 2 of 3 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2026: 6 of 20 companies on the "Worse" side.
36 other companies' latest entry also says "Restated".
- FY2024RestatedAnnual report
「Our group is working to improve and strengthen its expiration-date management systems by conducting regular physical inventories, thoroughly implementing and verifying other procedures, and using IT systems, with the aim of delivering safer, higher-quality products to medical, nursing and welfare facilities.」
The company continues to conduct physical inventories, verify procedures and manage expiration dates using IT systems. It also continues to identify the risks of health damage caused by expired products, cancellation of licenses and other approvals, and compensation costs. - FY2022RestatedAnnual report
「However, if, in the event of human error or a system failure within the group, products that have passed their expiration dates enter distribution and cause serious health damage, sales activities may be affected due to the cancellation of licenses and other approvals related to the sale of medical devices, a decline in trust in the group and other factors, and substantial costs may be incurred for compensation to patients and medical institutions and for improving and strengthening systems for managing expiration dates.」
The company continues to identify risks related to human error and system failures in expiration-date management, health damage, cancellation of licenses and other approvals, and compensation costs. - FY2020First statedAnnual report
「However, if, in the event of human error or a system failure within the group, products that have passed their expiration dates enter distribution and cause serious health damage, sales activities may be affected due to the cancellation of licenses and other approvals related to the sale of medical devices, a decline in trust in the group and other factors, and substantial costs may be incurred for compensation to patients and medical institutions and for improving and strengthening systems for managing expiration dates.」
The company has for the first time described, in relation to expiration-date management, the potential for expired products to enter distribution, serious health damage, cancellation of licenses and other approvals, compensation costs and costs to improve management systems.